Antimicrobial peptide developed with machine learning sequence optimization targets drug resistant Staphylococcus aureus in mice
Journal of Clinical Investigation · 16.06.2025 · 135 (12)
DOI: 10.1172/jci185430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 22.04.2025. Verfasst von Biswajit Mishra und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Machine Learning, Antimicrobial Peptides, Vancomycin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
As antimicrobial resistance rises, new antibacterial candidates are urgently needed. Using sequence space information from over 14,743 functional antimicrobial peptides (AMPs), we improved the antimicrobial properties of citropin 1.1, an AMP with weak antimethicillin resistant Staphylococcus aureus (MRSA) activity, producing a short and potent antistaphylococcal peptide, CIT-8 (13 residues). At 40 μg/mL, CIT-8 eradicated 1 × 10 8 drug-resistant MRSA and vancomycin resistant S . aureus (VRSA) persister cells within 30 minutes of exposure and reduced the number of viable biofilm cells of MRSA and VRSA by 3 log 10 and 4 log 10 in established biofilms, respectively. CIT-8 (at 32 μg/mL) depolarized and permeated the S . aureus MW2 membrane. In a mouse model of MRSA skin infection, CIT-8 (2% w/w in petroleum jelly) significantly reduced the bacterial burden by 2.3 log 10 ( P < 0.0001). Our methodology accelerated AMP design by combining traditional peptide design strategies, such as truncation, substitution, and structure-guided alteration, with machine learning–backed sequence optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.
- School of Pharmaceutical Sciences, and.
- School of Biomolecular Engineering & Biotechnology, Rajiv Gandhi Technological University, Gandhinagar, Bhopal, Madhya Pradesh, India.
- Department of Electrical and Computer Engineering, National Technical University of Athens, Athens, Greece.
- Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Molecular Biology, Cell Biology & Biochemistry, Brown University, Providence, Rhode Island, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH
Zitieren
APA
Mishra, B., Basu, A., Shehadeh, F., Felix, L., Kollala, S. S., Chhonker, Y. S., Naik, M. T., Dellis, C., Zhang, L., Ganesan, N., Murry, D. J., Gu, J., Sherman, M. B., Ausubel, F. M., Sotiriadis, P. P., & Mylonakis, E. (2025). Antimicrobial peptide developed with machine learning sequence optimization targets drug resistant Staphylococcus aureus in mice. Journal of Clinical Investigation, 135(12). https://doi.org/10.1172/jci185430
Vancouver
Mishra B, Basu A, Shehadeh F, Felix L, Kollala SS, Chhonker YS, et al. Antimicrobial peptide developed with machine learning sequence optimization targets drug resistant Staphylococcus aureus in mice. Journal of Clinical Investigation. 2025;135(12). doi:10.1172/jci185430
BibTeX
@article{Mishra2025,
author = {Mishra, Biswajit and Basu, Anindya and Shehadeh, Fadi and Felix, LewisOscar and Kollala, Sai Sundeep and Chhonker, Yashpal Singh and Naik, Mandar T and Dellis, Charilaos and Zhang, Liyang and Ganesan, Narchonai and Murry, Daryl J and Gu, Jianhua and Sherman, Michael B and Ausubel, Frederick M and Sotiriadis, Paul P and Mylonakis, Eleftherios},
title = {Antimicrobial peptide developed with machine learning sequence optimization targets drug resistant Staphylococcus aureus in mice},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {12},
doi = {10.1172/jci185430}
}
EUVIMED